Patient-specific Predictors of Haemolysis with Percutaneous Ventricular Assist Devices
Laboratory-defined haemolysis was common in patients with cardiogenic shock and pVAD, but clinically significant haemolysis was not. There was no association between haemolysis and on-device or 30-day mortality.
Authors
- Alexander E. Sullivan (ORCID: https://orcid.org/0000-0002-1755-0055)
- Kaushik V Amancherla (ORCID: https://orcid.org/0000-0003-3379-5834)
- Bret D. Alvis (ORCID: https://orcid.org/0000-0003-1138-1761)
- Eric Farber‐Eger (ORCID: https://orcid.org/0000-0003-0281-3796)
- Swaroop Bommareddi
- Hannah Granger (ORCID: https://orcid.org/0000-0002-7983-5910)
- Aniket S. Rali (ORCID: https://orcid.org/0000-0002-3778-9979)
- Quinn S. Wells (ORCID: https://orcid.org/0000-0003-3899-0313)
- Lena Tran (ORCID: https://orcid.org/0000-0003-4691-7087)
- Léonie Dupuis (ORCID: https://orcid.org/0000-0002-0494-6050)
- J Lukas Laws
- J O'leary (ORCID: https://orcid.org/0009-0000-8764-2548)
- Jonathan Napper
Institutions
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Cardiac failure review
- Published
- 2025-02-19
- DOI
- https://doi.org/10.15420/cfr.2024.30
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- American Heart Association
- Vanderbilt University
- International Society for Heart and Lung Transplantation
- Vanderbilt University Medical Center
- Abiomed
- National Institutes of Health